Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Catheter Cardiovasc Interv. 2013 Jun 25;83(1):10.1002/ccd.25021. doi: 10.1002/ccd.25021

Table 3.

Baseline characteristics of patients with an identifiable culprit artery

Characteristic No Collaterals (n=63) Collaterals (n=52) P value
Age (years) mean +/− SD 60 (+/− 12) 62 (+/− 11) 0.542
Men 46 (73%) 43 (83%) 0.217
Hypertension * 52 (83%) 39 (75%) 0.322
Hyperlipidemia 52 (83%) 44 (85%) 0.765
Diabetes mellitus 21 (33%) 16 (31%) 0.770
Current smoker 26 (41%) 15 (29%) 0.166
Former smoker 18 (29%) 18 (35%) 0.487
Prior angina 32 (51%) 21 (40%) 0.265
Prior MI 18 (29%) 17 (33%) 0.633
Prior PCI 18 (29%) 16 (31%) 0.797
Prior CABG 8 (13%) 11 (21%) 0.224
History of CHF 6 (10%) 0 0.031
History of arrhythmia 2 (3%) 5 (10%) 0.150
Prior stroke 2 (3%) 4 (8%) 0.407
Family history of CAD 35 (56%) 24 (46%) 0.273
Peripheral arterial disease 7 (11%) 11 (21%) 0.140
Left ventricular ejection fraction 0.644
 Normal 34 (54%) 23 (44%)
 Mild-moderately depressed 8 (13%) 13 (25%)
 Severely depressed 1 (2%) 0
Labs
Total cholesterol (mg/dL) 173 [138–204] 184 [150–227] 0.438
LDL (mg/dL) 110 [80–136] 117 [90–133] 0.416
HDL (mg/dL) 31 [24–41] 33 [28–43] 0.390
Triglycerides (mg/dL) 152 [76–199] 163 [86–215] 0.766
Troponin I (ng/mL) 2.30 [0.38–16.53] 2.14 [0.39–9.87] 0.527
Medications
Aspirin 59 (94%) 48 (92%) 1.000
Clopidogrel 29 (47%) 24 (46%) 0.947
Statin 55 (89%) 47 (90%) 0.772
Oral Hypoglycemic 4 (6%) 4 (8%) 1.000
Insulin 10 (16%) 16 (31%) 0.057
Beta Blocker 51 (82%) 41 (79%) 0.646
Calcium Channel Blocker 4 (6%) 4 (8%) 1.000
ACE-Inhibitor 37 (60%) 19 (37%) 0.014

Data are expressed as mean ± standard deviation (SD), median [25–75% interquartile range (IQR)], or as number (percentage), ACE= angiotensin converting-enzyme, CABG= coronary artery bypass graft surgery, CAD= coronary artery disease, CHF= congestive heart failure, HDL= high density lipoprotein, LDL = low density lipoprotein, MI= myocardial infarction, PCI= percutaneous coronary intervention.

*

patients treated with antihypertensive medication, and untreated patients with known systolic blood pressure ≥140mmHg or diastolic blood pressure ≥90mmHg

patients with total cholesterol level >200mg/dl, or current use of lipid-lowering drugs

as determined by left ventriculography or transthoracic echocardiography, normal left ventricular systolic function was defined as an ejection fraction of ≥55%, mild to moderately depressed left ventricular function was defined as an ejection fraction of 40–54%, and severely depressed left ventricular systolic function was defined as an ejection fraction of <40%.